GENETIC AND GENOMIC DETERMINANTS OF HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY AS TREATMENT SELECTION MARKERS FOR LETHAL PROSTATE CANCER...NEW AWARD

The Johns Hopkins University

Investigators